SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,401,069 | -25.4% | 2,132,873 | 0.0% | 0.03% | -23.8% |
| Q2 2023 | $9,917,859 | +0.6% | 2,132,873 | 0.0% | 0.04% | -12.5% |
| Q1 2023 | $9,853,873 | -47.3% | 2,132,873 | -7.8% | 0.05% | -57.9% |
| Q4 2022 | $18,693,419 | +20.1% | 2,313,542 | -17.5% | 0.11% | +15.2% |
| Q3 2022 | $15,569,000 | +6.5% | 2,805,197 | 0.0% | 0.10% | +12.5% |
| Q2 2022 | $14,615,000 | -2.9% | 2,805,197 | +53.1% | 0.09% | +12.8% |
| Q1 2022 | $15,057,000 | -36.1% | 1,831,755 | +15.7% | 0.08% | -36.6% |
| Q4 2021 | $23,564,000 | -22.4% | 1,583,579 | -1.5% | 0.12% | -25.5% |
| Q3 2021 | $30,365,000 | +2.3% | 1,607,466 | +0.7% | 0.16% | -1.8% |
| Q2 2021 | $29,686,000 | -8.4% | 1,596,882 | +12.2% | 0.17% | -17.2% |
| Q1 2021 | $32,392,000 | +39.8% | 1,423,205 | +33.4% | 0.20% | +39.0% |
| Q4 2020 | $23,170,000 | – | 1,067,258 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |